Cancer Neuroimaging Research Program

The Cancer Neuroimaging Research Program (CNRP) brings together specialists in imaging, oncology, neuroscience, cancer biology and data science to drive the discovery and clinical translation of neuroimaging technologies. Our goal is to pioneer and integrate imaging tools across the continuum of discovery and care, linking biological insight, data-driven interpretation and therapeutic development to advance precision care for individuals affected by cancer.

The Cancer Neuroimaging Research Program is an affiliate of the UT MD Anderson Cancer Neuroscience Program, one of the institution’s signature priority programs.

From Imaging Innovation to Clinical Impact

The Cancer Neuroimaging Research Program (CNRP) pursues its goal through four interconnected research areas: innovation, intelligence, intervention and insights. Together, they provide an integrated framework for moving neuroimaging discoveries from technology development and biological investigation to clinical application.

1. Innovation advances next generation neuroimaging technologies including acquisition and image reconstruction techniques, molecular and metabolic imaging agents, and image-based biomarkers.
2. Intelligence harnesses data science and computational strategies that transform imaging data into clinically actionable decision tools.
3. Intervention develops image-guided therapies, methods for predicting and measuring regional drug delivery, and imaging strategies for the early assessment of therapeutic response.
4. Insights applies advanced preclinical and clinical neuroimaging technologies to investigate cancer biology and the effects of cancer and cancer-directed therapies on the nervous system.

Explore CNRP research and collaboration